Carlos Pantoja, MD, PhD

Carlos Pantoja, MD, PhD has an extensive work experience in various roles and companies. Carlos currently works as the Medical Director, Clinical Development at Amunix Pharmaceuticals since August 2022. Prior to that, they served as an Advisor at Shifthive from June 2020. In Perspectum Ltd, they held multiple positions including Medical Director from April 2021 to August 2022, Medical Advisor from April 2021 to November 2021, and Clinical Project Manager from April 2020 to April 2021. Carlos also served as a Scientific Advisor at Circumvent Pharmaceuticals from April 2020 to August 2022. Additionally, Carlos worked as a Visiting Professor at Universidade de Brasília from February 2019 to March 2021, and as a Visiting Scientist at Max Planck Institute of Neurobiology from January 2017 to January 2020. Carlos began their postdoctoral fellowship at UC Berkeley in an unspecified month of 2010 and completed it in July 2016.

Carlos Pantoja, MD, PhD, began their education in 1996 at Universidade de Brasília, where they pursued a Doctor of Medicine (M.D.) degree in Medicine. Carlos successfully completed their studies in 2003. Following this, they enrolled at the University of California, San Francisco, beginning in 2003 and ending in 2009. During this period, Carlos pursued a Ph.D. degree in Biochemistry and Molecular Biology. These educational experiences formed the foundation for their medical and research career.